NEW YORK (360Dx) — Royal Philips said this week that it has partnered with Oxford University Hospitals (OUH) NHS Foundation Trust  to use the company's Intellisite digital pathology system to create a digital pathology network across a number of UK hospitals.
The IntelliSite Pathology Solution is a whole-slide imaging system that enables the review and interpretation of digital surgical pathology slides prepared from biopsied tissue. It was CE-IVD marked in 2014 and cleared by the US Food and Drug Administration in 2017.
Under the terms of the alliance, OUH will deploy the system at its John Radcliffe Hospital in Oxford, which will act as the central laboratory service for partner sites at Milton Keynes University Hospital NHS Foundation Trust and Great Western Hospital NHS Foundation Trust in Swindon. The network is expected to reduce the need to transport slides between sites in order for clinicians to collaborate remotely.
"This partnership aims to modernize patient care and offer innovative world-leading services," Clare Verrill, honorary consultant in cellular pathology at OUH, said in a statement. "Initially starting with some specialist areas, we hope to soon make our pathology services fully digital, meaning our laboratory teams can maximize efficiency and focus on analyzing samples rather than spending time manually transporting slides between hospitals."
Philips said that the network is expected to be fully installed in the third quarter.